Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012

2nd Annual World Orphan Drug Congress 2012

17 Oct 2012 - 18 Oct 2012 - Barcelona, Spain

Bookmark and Share

In order to discuss major concerns, the newest solutions and challenges connected with prevention, diagnosis and treatment of rare diseases, Fleming Europe has organized its 2nd Annual Orphan Drug Congress 2012. On 17 – 18 October 2012 the top-level pharmaceutical experts in orphan drug development, regulatory affairs & pricing will gather in Barcelona to discuss this year's critical issues.

Focused interactive discussions integrated between individual presentation blocks will provide enough space and a unique opportunity to exchange ideas with industry peers and get the answers from our speakers.

The attendees will have the opportunity to:

  • Understand the infrastructure in order to gain approval in emerging markets 
  • Gain critical insights behind the successful development, authorization and  reimbursement of rare disease drugs 
  • Find out how to regulate the use of social media for orphan drugs & rare diseases 
  • Explore the importance of communication Between Pharma, Patient & HTA Bodies 
  • Meet the top executives and experts from leading pharmaceutical companies as well as  from medium and small pharma companies with the focus on rare and neglected    diseases

For further details please request the event brochure

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos